Accepting graduate students

Research themes

Keywords

Research affiliations

Research interests

Research summary

Dr. Grant Hatch’s laboratory studies the regulation of the metabolism of the phospholipid cardiolipin. Specifically, we are studying the regulation of cardiolipin biosynthesis and remodeling in mammalian tissues and cells in the childhood X-linked genetic disease Barth Syndrome and in chronic diseases such as obesity and Type 2 diabetes.

Biography

Dr. Hatch has a broad background in lipid biochemistry, with specific training and expertise in lipid species analysis, enzyme purification and characterization, molecular and whole animal biology. His research includes identification, purification and characterization of monolysocardiolipin acyltransferase-1 (MLCL AT-1), the lipid enzymatic activity present in HADHA. As a Canada Research Chair in Molecular Cardiolipin Metabolism and PI on several national funded grants in Canada, Dr. Hatch has uncovered many novel facets of cardiolipin biology that made it possible to attract and train high quality personnel. He has successfully administered projects (e.g. staffing, research protections, budget), fruitfully and productively collaborated with other researchers, and produced many high quality peer-reviewed publications and reviews from each project.

Education

Awards

Google Scholar profile

Visit Grant Hatch's Google Scholar profile for a complete listing.

Grant Hatch's profile

Contact us

Pharmacology and Therapeutics
Max Rady College of Medicine
A205 Chown Bldg., 753 McDermot Avenue
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0T6 Canada

204-789-3553